Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
Completed · Phase 1
Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific
In brief
Phase I trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic or unresectable solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
Key facts
- Study ID
- NCT00004242
- Run by
- National Cancer Institute (NCI)
- People needed
- 30
- Starts
- 1999-10-01
- Last updated by the study team
- 2013-02-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
- Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.